Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism

Neurochemistry International

Volumn 33, Issue 2, 1998, Pages 143-154

  Wang, Jianping ^a,b   Dunn, Adrian J ^b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

ACTH; Corticosterone; Interleukin 6; Serotonin; Tryptophan

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ACUTE PHASE PROTEIN; CHLORISONDAMINE; CORTICOSTERONE; CORTICOTROPIN; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; SEROTONIN; SERUM AMYLOID A; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DOSE TIME EFFECT RELATION; HEAT TREATMENT; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NEUROCHEMISTRY; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; SEROTONIN METABOLISM; TRYPTOPHAN BRAIN LEVEL;

ADRENAL CORTEX; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BRAIN; CHLORISONDAMINE; CORTICOSTERONE; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; GANGLIONIC BLOCKERS; HYDROXYINDOLEACETIC ACID; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-6; KINETICS; MALE; MICE; NITRIC OXIDE SYNTHASE; RECOMBINANT PROTEINS; SEROTONIN; TRYPTOPHAN;

EID: 0032144130     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(98)00016-3     Document Type: Article

References (65)

1. Akira, S., Taga, T., Kishimoto, T., 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54, 1-78.
2. Barton, B.E., 1996. The biological effects of interleukin-6. Med. Res. Rev. 16, 87-109.
3. Baumann, H., Gauldi, J., 1994. The acute phase response. Immunol. Today 15, 74-80.
4. Benigni, F., Fantuzzi, G., Sacco, S., Sironi, M., Pozzi, P., Dinarello, C.A., Sipe, J.D., Poli, V., Cappelletti, M., Paonessa., G., et al., 1996. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of IL-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood 87, 1851-1854.
5. Besedovsky, H.O., del Rey, A., Sorkin, E., Dinarello, C.A., 1986. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233, 652-654.
6. Bishai, I., Coceani, F., 1996. Differential effects of endotoxin and cytokines on prostaglandin E(2) formation in cerebral microvessels and brain parenchyma: Implications for the pathogenesis of fever. Cytokine 8, 371-376.
7. Bocci, V., 1991. Interleukins: clinical pharmacokinetics and practical implications. Clin. Pharmacokinet. 21, 274-284.
8. Castell, J.V., Gómez-Lechón, M.J., David, M., Andus, T., Geiger, T., Trullenque, R., Fabra, R., Henrich, P.C., 1989. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Letts 242, 237-239.
9. Curzon, G., 1990. Serotonin and appetite. Ann. N.Y. Acad. Sci. 600, 521-531.
10. del Rey, A., Besedovsky, H.O., 1992. Metabolic and neuroendocrine effects of pro-inflammatory cytokines. Europ. J. Clin. Invest. 22, 10-15.
11. Dinarello, C.A., Cannon, J.G., Mancilla, J., Bishai, I., Lees, J., Coceani, F., 1991. Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Res. 562, 199-206.
12. Dunn, A.J., 1988a. Stress-related changes in cerebral catecholamine and indoleamine metabolism: lack of effect in adrenalectomy and corticosterone. J. Neurochem. 51, 406-412.
13. Dunn, A.J., 1988b. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci. 43, 429-435.
14. Dunn, A.J., 1992a. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J. Pharmacol. Exptl. Therapeut. 261, 964-969.
15. Dunn, A.J., 1992b. The role of interleukin-1 and tumor necrosis factor α in the neurochemical and neuroendocrine responses to endotoxin. Brain Res. Bull. 29, 807-812.
16. Dunn, A.J., 1993a. Neurochemical methods for evaluating cerebral biogenic amine responses to cytokines and their involvement in the central actions of interleukin-1. In: De Souza, E.B., (Ed.) Neurobiology of Cytokines. Academic Press, Inc. San Diego, pp. 209-222.
17. Dunn, A.J., 1993b. Nitric oxide synthase inhibitors prevent the cerebral tryptophan and serotonergic responses to endotoxin and interleukin-1. Neurosci. Res. Commun. 13, 149-156.
18. Dunn, A.J., Chuluyan, H., 1992. The role of cyclo-oxygenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis: dependence on the route of injection. Life Sci. 51, 219-225.
19. Dunn, A.J., Welch, J., 1991. Stress-and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activation. J. Neurochem. 57, 1615-1622.
20. Fernstrom, J.R., Wurtman, R.J., 1971. Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science 173, 149-152.
21. Gemma, C., De Luigi, A., De Simoni, M.G., 1994. Permissive role of glucocorticoids on interleukin-1 activation of the hypothalamic serotonergic system. Brain Res. 651, 169-173.
22. Guild, A.L., Dunn, A.J., 1982. Dopamine involvement in ACTH-induced grooming behavior. Pharmacol. Biochem. Behav. 17, 31-36.
23. Hartmann, E., Greenwald, D., 1984. Tryptophan and human sleep: an analysis of 43 studies. In: Schlossberger, H.G., Kochen, W., Linzen, B., Steinhart (Eds), Progress in Tryptophan and Serotonin Research. Walter de Gruyter, Berlin, pp. 297-304.
24. Hooghe-Peters, E., Velkeniers, B., Vanhaelst, L., Hooghe, R., 1991. Interleukin-1, interleukin-6: messengers in the neuroendocrine immune system? Path. Res. Pract. 187, 622-625.
25. Hrboticky, N.M., Leiter, L.A., Anderson, G.H., 1985. Effects of L-tryptophan on short term food intake in lean men. Nutr. Res. 5, 595-607.
26. Jones, T.H., 1994. Interleukin-6 an endocrine cytokine. Clin. Endocrinol. 40, 703-713.
27. Katsuura, G., Gottschall, P.E., Dahl, R.R., Arimura, A., 1988. Adrenorcorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin. Endocrinol. 122, 1773-1779.
28. Lavicky, J., Dunn, A.J., 1995. Endotoxin administration stimulates cerebral catecholamine release in freely moving rats as assessed by microdialysis. J. Neurosci. Res. 40, 407-413.
29. Libert, C., Brouckaert, P., Shaw, A., Fiers, W., 1990. Induction of interleukin-6 by human and murine recombinant interleukin-1 in mice. Europ. J. Immunol. 20, 691-694.
30. Lyson, K., McCann, S.M., 1991. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinol. 54, 262-266.
31. Lyson, K., McCann, S.M., 1992. Involvement of arachidonic acid cascade pathways in interleukin-6-stimulated corticotropin-releasing factor release in vitro. Neuroendocrinol. 55, 708-713.
32. Mantovani, A., Bussolino, F., Dejana, E., 1992. Cytokine regulation of endothelial cell function. FASEB J. 6, 2591-2599.
33. Matta, S.G., Weatherbee, J., Sharp, B.M., 1992. A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-1β. Neuroendocrinol. 56, 516-525.
34. Mulé, J.J., McIntosh, J.K., Jablons, D.M., Rosenberg, S.A., 1990. Antitumor activity of recombinant interleukin-6 in mice. J. Exptl. Med. 171, 629-636.
35. Murray, L., Zalcman, M.S., Nance, D.M., Dyck, D.G., Greenberg, A.H., 1994. Interleukin (IL)-1, IL-2 and IL-6 induce cytokine-specific alterations of exploratory behavior. Soc. Neurosci. Abstr. 20, 1603.
36. Muscaritoli, M., Meguid, M.M., Beverly, J.L., Yang, Z.-J., Cangiano, C., Rossi-Fanelli, F., 1996. Mechanism of early tumor anorexia. J. Surg. Res. 60, 389-397.
37. Naitoh, Y., Fukata, J., Tominaga, T., Nakai, Y., Tamai, S., Mori, K., Imura, H., 1988. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem. Biophys. Res. Commun. 155, 1459-1463.
38. Nakamura, A., Kohsaka, T., Johns, E.J., 1993. Differential regulation of interleukin-6 production in the kidney by the renal sympathetic nerves in normal and spontaneously hypertensive rats. J. Hypertension 11, 491-497.
39. Navarra, P., Tsagarakis, S., Faria, M.S., Rees, L.H., Besser, G.M., Grossman, A.B., 1991. Interleukin-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinol. 128, 37-44.
40. Opp, M., Obal, F., Cady, A.B., Johannsen, L., Krueger, J.M., 1989. Interleukin-6 is pyrogenic but not somnogenic. Physiol. Behav. 45, 1069-1072.
41. Perlstein, R.S., Mougey, E.H., Jackson, W.E., Neta, R., 1991. Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo. Lymph. Cytok. Res. 10, 141-146.
42. Podor, T.J., Jirik, F.R., Loskutoff, D.J., Carson, D.A., Lotz, M., 1989. Human endothelial cells produce IL-6. Lack of responses to exogenous IL-6. Ann. N.Y. Acad. Sci. 557, 374-385.
43. Preiser, J.C., Schmartz, D., Van der Linden, P., Content J., Vanden Brussche, P., Buurman, W., Sebald, W., Dupont, E., Pinsky, M.R., Vincent, J.-L., 1991. Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog. Cytokine 3, 1-4.
44. Rapoport, M.I., Beisel, W.R., 1971. Studies of tryptophan metabolism in experimental animals and man during infectious illness. Amer. J. Clin. Nutr. 24, 807-814.
45. Rivier, C., Vale, W., 1991. Stimulatory effect of interleukin-1 on adrenocorticotropin secretion in the rat: is it modulated by prostaglandins? Endocrinol. 129, 384-388.
46. Schöbitz, B., Pezeshki, G., Pohl, T., Hemmann, U., Heinrich, P.C., Holsboer, F., Reul, J.M.H.M., 1995. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J. 9, 659-664.
47. Sébire, G., Emilie, D., Wallon, C., Héry, C., Devergne, O., Delfraissy, J.-F., Galanaud, P., Tardieu, M., 1993. In vitro production of IL-6, IL-1β, and tumor necrosis factor-α by human embryonic microglial and neural cells. J. Immunol. 150, 1517-1523.
48. Shaghaghi, E.K., Wu, Y., Pallardy, M., Lebrec, H., Jacquot, C., Gard ier, A.M., 1996. Activation of the anterior hypothalamic serotoninergic system by interleukin-6 and interleukin-1β: in vivo microdialysis studies in awake F344 rats. Soc. Neurosci. Abstra. 22, 848.
49. Shalaby, M., Waage, A., Aarden, L., Espevik, T., 1989. Endotoxin, tumor necrosis factor-γ and interleukin-1 induce interleukin-6 production in vivo. Clin. Immunol. Immuopathol. 53, 488-498.
50. Sjoerdsma, A., Palfreyman, M.G., 1990. History of serotonin and serotonin disorders. Ann. N.Y. Acad. Sci. 600, 1-7.
51. Smagin, G.N., Swiergiel, A.H., Dunn, A.J., 1996. Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: relationship to plasma corticosterone. Pshychoneuroendocrinol. 21, 83-93.
52. Spath-Schwalbe, E., Schrezenmeier, M., Bornstein, S.R., Burger, K., Porzsolt, F., Born, J., 1996. Endocrine effects of recombinant 6 in man. Neuroendocrinol. 63, 237-243.
53. Spinedi, E., Hadid, R., Daneva, T., Gaillard, R.C., 1992. Cytokines stimulate the CRH but not the vasopressin neuronal system: evidence for a median eminence site of interleukin-6 action. Neuroendocrinol. 56, 46-53.
54. Stouthard, J.M.L., Romijn, J.A., Van der Poll, T., Endert, E., Klein, S., Bakker, P.J.M., Veenhof, C.H.N., Sauerwein, H.P., 1995. Endocrinologic and metabolic effects of interleukin-6 in humans. Amer. J. Physiol. 268, E813-819.
55. Strassmann, G., Fong, M., Kenney, J.S., Jacob, C.O., 1992. Evidence for the involvement of interleukin-6 in experimental cancer cachexia. J. Clin. Invest. 89, 1681-1684.
56. Strassmann, G., Fong, M., Windsor, S., Neta, R., 1993. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine 5, 285-290.
57. Terao, A., Oikawa, M., Saito, M., 1993. Cytokine-induced change in hypothalamic norepinephrine turnover: involvement of corticotropin-releasing hormone and prostaglandins. Brain Res. 622, 257-261.
58. Terao, A., Saito, M., 1993. Possible role of IL-6 in IL-1 induced plasma iron and corticosterone responses in rats. Biomed. Res. 14, 301-303.
59. Van Snick, J., 1990. Interleukin-6: an overview. Ann. Rev. Immunol. 8, 253-278
60. Wang, J.P., Ando, T., Dunn, A.J., 1997. The effect of homologous interleukin-1, interleukin-6 and tumor necrosis factor α on the core body temperature of mice. Neuroimmunomodulation 4, 230-236.
61. Wang, J.P., Dunn, A.J. (submitted for publication). The role of Interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis induced by endotoxin and interleukin-1β.
62. Watanabe, T., Morimoto, A., Sakata, Y., Murakami, N., 1990. ACTH response induced by interleukin-1 is mediated by CRF secretion stimulated by hypothalamic PGE. Experientia 46, 481-484.
63. Watkins, L.R., Maier, S.F., Goehler, L.E., 1995. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci. 57, 1011-1026.
64. Wurtmann, J.J., Wurtman, R.J., Growdon, J.H., Henry, P., Lipscomb, A., Zeisel, S.H., 1981. Carbohydrate craving in obese people: suppression by treatments affecting serotoninergic transmission. Intl. J. Eating Dis. 1, 2-15.
65. Zalcman, S., Green-Johnson, J.M., Murray, L., Nance, D.M., Dyck, D., Anisman, H., Greenberg, A.H., 1994. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain. Res. 643, 40-49.